Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 2 10Phase 3 9Phase 1 5Phase 2/3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Unknown 30Completed 20Recruiting 11Not yet recruiting 10Active not recruiting 5Withdrawn 4Terminated 2

Sponsor Class

OTHER 494INDUSTRY 432NIH 96NETWORK 7OTHER_GOV 5FED 1

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 2Lymphoid 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Stomatitis 1Prostatic Neoplasms 1Ovarian Neoplasms 1Mouth Neoplasms 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 1nabiximols 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Rituximab 1Nivolumab 1ETC-159 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Active not recruiting × OTHER_GOV × Clear all
NCT05308732 2026-05-01

Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy

Instituto Nacional de Cancer, Brazil

Phase 1 Active not recruiting
20 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT05969314 2025-04-11

To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

Tata Memorial Hospital

Phase 1 Active not recruiting
12 enrolled
BreastHead & Neck

Breast Neoplasms, Mouth Neoplasms

NCT05917860 2025-02-17

NeoADT-TULSA

Turku University Hospital

Phase 1 Active not recruiting
15 enrolled
Genitourinary

Prostatic Neoplasms

NCT02521844 2024-10-08

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

EDDC (Experimental Drug Development Centre), A*STAR Research Entities

Phase 1 Active not recruiting
89 enrolled
Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT03245021 2024-07-30

1stFLOR

Austin Health

Phase 1 Active not recruiting
39 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡